{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-08",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Portage",
      "state": "MI",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Devices",
      "event_id": "79444",
      "recalling_firm": "Phadia US Inc",
      "address_1": "4169 Commercial Ave",
      "address_2": "N/A",
      "postal_code": "49002-9701",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide Distribution",
      "recall_number": "Z-1312-2018",
      "product_description": "ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01).    ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma.  To be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.",
      "product_quantity": "950 total",
      "reason_for_recall": "The stability specifications of ImmunoCAP Allergen c5, Ampicilloyl were not met.",
      "recall_initiation_date": "20171218",
      "center_classification_date": "20180405",
      "termination_date": "20190327",
      "report_date": "20180411",
      "code_info": "Lots   990DS, Exp 2017.12.31  990DT, Exp 2018.01.31  990DW, Exp 2018.03.31  990DX, Exp, 2018.05.31  990DY"
    }
  ]
}